DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Raising forecast for the current fiscal year

30-Aug-2018 / 15:51 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Bremen, August 30, 2018 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development:

  • For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in revenues to EUR 16.0 million to EUR 16.5 million is now expected (previous forecast for fiscal year 2018: significant decrease to EUR 14.5 million to EUR 15.0 million).
  • For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in the EBIT (earnings before interest and taxes) is expected to EUR 5.5 million to EUR 6.0 million (previous forecast for fiscal year 2018: decrease in EBIT to EUR 3.0 million to EUR 3.5 million).

************************************************************************

Contact:

Dr. Hannemann, Robert / CFO

30-Aug-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet:http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange

 
End of Announcement DGAP News Service

719191  30-Aug-2018 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=719191&application_name=news&site_id=zonebourse